Compare Abeona Therapeutics Inc (ABEO) vs SMX Security Matters plc (SMX) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abeona Therapeutics Inc vs SMX Security Matters plc — how do they compare? Abeona Therapeutics Inc trades at $6.74 (market cap $373.32M), while SMX Security Matters plc trades at $14.56 (market cap $15.08M). The key difference: Abeona Therapeutics Inc is far larger — about 24.8× SMX Security Matters plc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, SMX Security Matters plc nearer its low. Which is the better fit depends on your goals.
| ABEO | SMX | |
|---|---|---|
Market Cap | $373.32M | $15.08M |
Sector | Health | Technology |
52-Week High | $7.23 | $569.32K |
52-Week Low | $4.17 | $12.87 |
Enterprise Value | $228.22M | $12.05M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ABEO trades at $6.31, down 1.41% today, with a bullish technical outlook supported by moving averages. The company reported Q1 2026 results with revenue growth and beat EPS expectations, while maintaining strong profitability margins. Recent news highlights expansion of treatment centers and new cell therapy licensing.
Outlook remains positive with analyst consensus favoring Buy ratings (66.67%), though high RSI indicates potential near-term overbought conditions. Key risks include negative operating cash flow and reliance on new treatment adoption. Upside depends on continued commercial execution and pipeline advancements.
SMX (Security Matters PLC) trades at $16.955, up 12.66% today, following two reverse stock splits in May and June 2026. The technical outlook is neutral with mixed moving averages and oscillators, while fundamentals show a P/B of 1.84 but negative ROE and ROA. Recent news highlights the company's focus on recycled plastic traceability and regulatory tailwinds from state recycling mandates.
Outlook is speculative given negative profitability and recent corporate actions. Investment opportunity hinges on adoption of its Circularity-as-a-Service platform, but risks include execution challenges and intense competition in sustainability tech. Wall Street sentiment appears cautious pending evidence of revenue growth and margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →
